PEA3 (16) Antibody sc-113 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPEA3 (16) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-113
NCBI Gene AliasesPEA3, E1AF, Pea3, PEAS3, Pea-3, E1A-F
Antibody TypePrimary Antibodies
Reactivitymouse, rat, human
Quantity200 µg/ml
ApplicationsWB, IP, IF
Clone16
FormatPurified
ClonalityMonoclonal
Conjugate/TagUnconjugated
Hostmouse
NCBI Full Gene NameETS variant transcription factor 4, ets variant 4
TargetPEA3
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 ActivationHum MutatMay 6, 2026Xue Meng, Jiaxi Zhang, Ning Zhang, Yuqi Hou, Yimeng Li, Jia Kang, Ruxin Li, Yinghui Shi, Juan Wang, Lixin Cheng, et al.extracted. Protein complexes were enriched by coimmunoprecipitation (Co‐IP) using anti‐ETV4 antibody (sc‐113, Santa Cruz). LC‐MS/MS and label‐free quantitative proteomics analysis were carried out at Aksomics

(2) ETV4-Mediated PD-L1 Upregulation Promotes Immune Evasion and Predicts Poor Immunotherapy Response in MelanomaOncology ResearchJanuary 1, 2026Tao Zhu, Taofeng Wei, Mingdong Yang, Junjun Xu, Huifang Jiang, Wei He, Juyan Zheng, Haibin Daichemiluminescence system (Tanon, Shanghai, China). The primary antibodies used were as follows: anti-ETV4 (sc-113, 1:1000, Santa Cruz, Dallas, TX, USA), anti-PD-L1 (ab213524, 1:1000, Abcam, Cambridge, Cambridgeshire,

(3) Topoisomerase I Inhibition in ETV4-overexpressed Non-Small Cell Lung Cancer Promotes Replication and Transcription Mediated R-Loop Accumulation and DNA DamageAdvanced science (Weinheim, Baden-Wurttemberg, Germany)September 1, 2025Zhang J, Wang Y, Cao S, Xie SM, Liu B, Li Y, Hou Y, Meng X, Ruan M, Bu D, et al.as input control, while the remaining lysates were incubated with antibodies against ETV4 antibody (sc‐113, Santa Cruz), Flag (14793, CST), His (66005‐1‐lg, Proteintech), HA (sc‐7392, Santa Cruz), SUPT16H (28598‐1‐AP,

(4) Differential expression of PEA3 in odontogenic cysts and tumorsJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral PathologySeptember 1, 2023Tun KM, Kitkumthorn N, Bumalee D, Arayapisit T, Lapthanasupkul P.

(5) Knockdown of ETV4 promotes autophagy-dependent apoptosis in GBM cells by reducing the transcriptional activation of EMP1Oncology lettersFebruary 1, 2022Wang J, Sun C, Li J, Jiang H, Qiu Y, Gong M.Institutes of Health). The following primary antibodies were used: Mouse anti-ETV4 (1:1,500; cat. no. sc-113; Santa Cruz Biotechnology, Inc.), rabbit anti-EMP1 (1:1,000; cat. no. ab230445; Abcam), mouse anti-GAPDH

(6) ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signalingCell death discoveryMay 29, 2021Zhu T, Zheng J, Zhuo W, Pan P, Li M, Zhang W, Zhou H, Gao Y, Li X, Liu Z.Bio-Rad gel image analysis system. The following primary antibodies were used in this study: anti-ETV4 (sc-113, Santa Cruz), anti-HK2 (22029-1-AP, Proteintech), anti-LDHA (19987-1-AP, Proteintech), anti-PDK1 (3062

(7) Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaTranslational oncologyOctober 1, 2020Wang J, Sato K, O'Donnell E, Singla A, Yaguare S, Aldahamsheh O, Batko B, Borjihan H, Tingling J, Zhang J, et al.Cell Signaling Technology. Antibodies against Twist1 (sc-81417), vimentin (sc-6260), N-cadherin (sc-8424), ETV4 (sc-113), ECT2 (sc-514750), and ALDH (sc-166362) were purchased from Santa Cruz (Santa Cruz, TX). Antibodies

(8) ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent mannerCancer lettersJuly 10, 2020Xu L, Hu H, Zheng LS, Wang MY, Mei Y, Peng LX, Qiang YY, Li CZ, Meng DF, Wang MD, et al.

(9) GPR30 expression and function in breast cancer cells are induced through a cis‑acting element targeted by ETS factorsOncology ReportsMarch 10, 2020David Segura‑Bautista, Aleida Olivares, Patricia Casas‑Gonz�lez, Edmundo Bonilla, Zayil Salazar, Marco Allán P�rez‑Solisab39742; Abcam), anti‑E26 transformation‑specific (ETS) translocation variant (ETV4; 1:100; cat. no. sc‑113; Santa Cruz Biotechnology, Inc.), anti‑ETV5 (1:250; cat. no. sc‑22807; Santa Cruz Biotechnology, Inc.) and

(10) A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulationModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncMarch 1, 2020Le Loarer F, Cleven AHG, Bouvier C, Castex MP, Romagosa C, Moreau A, Salas S, Bonhomme B, Gomez-Brouchet A, Laurent C, et al.

(11) PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathwayCancer lettersJune 28, 2019Yang QX, Zhong S, He L, Jia XJ, Tang H, Cheng ST, Ren JH, Yu HB, Zhou L, Zhou HZ, et al.

(12) CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignanciesGenes, chromosomes & cancerSeptember 1, 2018Schaefer IM, Dal Cin P, Landry LM, Fletcher CDM, Hanna GJ, French CA.

(13) ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesisBreast cancer research : BCRJuly 11, 2018Dumortier M, Ladam F, Damour I, Vacher S, Bièche I, Marchand N, de Launoit Y, Tulasne D, Chotteau-Lelièvre A.

(14) "Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, ""undifferentiated small round cell tumors"". A clinicopathologic, immunophenotypic and molecular analysis"Annals of diagnostic pathologyJune 1, 2018Machado I, Yoshida A, Morales MGN, Abrahão-Machado LF, Navarro S, Cruz J, Lavernia J, Parafioriti A, Picci P, Llombart-Bosch A.

(15) Genetic analyses of undifferentiated small round cell sarcoma identifies a novel sarcoma subtype with a recurrent CRTC1-SS18 gene fusionThe Journal of pathologyJune 1, 2018Alholle A, Karanian M, Brini AT, Morris MR, Kannappan V, Niada S, Niblett A, Ranchère-Vince D, Pissaloux D, Delfour C, et al.

(16) Transcriptomic definition of molecular subgroups of small round cell sarcomasThe Journal of pathologyMay 1, 2018Watson S, Perrin V, Guillemot D, Reynaud S, Coindre JM, Karanian M, Guinebretière JM, Freneaux P, Le Loarer F, Bouvet M, et al.

(17) Transcription activated p73-modulated cyclin D1 expression leads to doxorubicin resistance in gastric cancerExperimental and therapeutic medicineFebruary 1, 2018Ji ZP, Qiang L, Zhang JL.ΔΝp73 (cat. no. SC-70966; 1:1,000), cyclin D1 (cat. no. SC-4074; 1:1,000), cleaved caspase-3 (cat. no. SC-113,427; 1:1,000), activator protein 1 (AP-1; cat. no. SC-8047; 1:1,000) and β-actin (cat. no. SC-58673,

(18) ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumorOncotargetDecember 26, 2017Zeng S, Seifert AM, Zhang JQ, Kim TS, Bowler TG, Cavnar MJ, Medina BD, Vitiello GA, Rossi F, Loo JK, et al.(D16H11) were purchased from Cell Signaling Technology. Other antibodies included anti-human ETV4 (SC-113, Santa Cruz), anti-human COP1 (ab56400, Abcam), lamin B1 (PA5-19468, Invitrogen), and anti-active β-catenin

(19) Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumorsPathology, research and practiceSeptember 1, 2017Machado I, Yoshida A, López-Guerrero JA, Nieto MG, Navarro S, Picci P, Llombart-Bosch A.

(20) CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular studyHistopathologySeptember 1, 2017Yoshida A, Arai Y, Kobayashi E, Yonemori K, Ogura K, Hama N, Mukai W, Motoi T, Kawai A, Shibata T, et al.

Be the First to Write a Review!

PEA3 (16) Antibody

PEA3 (16) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (82)

Reviews

PEA3 (16) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map